Ellanse Formulation Choice: An Underestimated Risk Factor

Ellanse is a collagen-stimulating filler built around polycaprolactone (PCL) microspheres. Its unique feature is offering four formulations — S, M, L, and E — each corresponding to a different duration of effect. This multi-formulation design gives practitioners flexibility, but it also introduces a commonly overlooked issue: choosing the wrong formulation can significantly increase complication risk and management difficulty.

In clinical practice, I have managed a substantial number of Ellanse complication cases and observed a clear trend: complications from longer-lasting formulations (L and E) are consistently more challenging to resolve than those from shorter-acting ones (S and M).

> Key Insight: "The longer it lasts, the better" is many patients' instinct, but with collagen stimulators, longer duration means PCL microspheres remain in tissue longer, the body interacts with them longer, and potential risks increase accordingly.

Fundamental Differences Between the Four Formulations

PCL Microsphere Characteristics

Recommended Use Versus Clinical Reality

How Formulation Affects Complications

Nodule Formation Risk

The longer PCL microspheres remain in tissue, the greater the chance of nodule formation:

Extraction Difficulty

When Ellanse removal is needed, formulation directly affects surgical complexity:

> Key Insight: When Ellanse L or E develops complications, management is substantially more difficult than with S or M. This does not mean longer formulations are inherently bad — it means the trade-offs must be fully understood before making a choice.

Typical Complication Scenarios by Formulation

S Type: The Most Forgiving Choice

S type has the lowest PCL content and fastest degradation, making it the lowest-risk formulation:

• Nodule formation is rare and usually small

• Even if problems arise, significant improvement typically occurs within 12–18 months

• If extraction is needed, the thin capsule makes removal relatively straightforward

M Type: The Most Common Balanced Choice

M type is the most widely used formulation, with intermediate complication characteristics:

• Nodules may appear 6–12 months post-injection

• Steroid injections may help with early nodules

• Extraction is usually achievable in a single session

L Type: Risk Begins to Escalate

L type's increased PCL content and duration bring elevated management challenges:

• Nodule formation risk is higher than M type

• Thicker capsules reduce steroid and 5-FU penetration

• Extraction may require more refined ultrasound guidance

• Some cases may need staged extraction

E Type: Highest Risk

E type has the longest duration and highest PCL content, with the greatest complication risk and management difficulty:

• Highest nodule formation risk

• Capsules may be very thick and mature

• Medical treatment is usually of limited effect

• Extraction surgery is most complex

• Multiple sessions may be necessary

The Critical Role of Ultrasound Across Formulations

Ultrasound Appearance by Formulation

Formulation-Specific Extraction Strategy

S/M Type Strategy

• Typically achievable through a single pinhole

• Direct extraction after ultrasound localization

• Single-session completion usually possible

L/E Type Strategy

• May require multiple entry points

• Capsule fragmentation before stepwise extraction

• Staged approach may be safer

• More intensive post-procedure ultrasound follow-up required

Factors to Consider Before Choosing a Formulation

For Patients

For Practitioners

Already Injected a Long-Acting Formulation?

If you have had Ellanse L or E injected and are experiencing nodules, asymmetry, or other problems, there is no need to panic. The important step is seeking professional evaluation early:

Ultrasound assessment: Confirm PCL residual location, extent, and capsule condition

Conservative treatment trial: For early inflammatory nodules, steroids or 5-FU may be attempted first

Minimally invasive extraction: When medical treatment fails, ultrasound-guided extraction is the definitive solution

For more on Ellanse removal, see Can Ellanse Be Removed?

Further reading:

• Collagen Stimulator Nodules: What to Do When 5-FU Fails

• Minimally Invasive Filler Lump Extraction Technique

Book an ultrasound evaluation

About the Author

Dr. Liu Ta-Ju

• Current Position: Director, Liusmed Clinic

• Specialties: Minimally invasive surgery, filler complication repair, ultrasound-guided extraction

• Experience: 15+ years of clinical minimally invasive surgery; over 10,000 successful cases

• Philosophy: "Ellanse formulation choice is not just about how long the results last — it is about how difficult complications will be to manage if they arise. Before deciding, make sure you understand the complete risk picture."